357 related articles for article (PubMed ID: 22560979)
61. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
[TBL] [Abstract][Full Text] [Related]
62. Regional Systems of Care to Optimize Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Stub D; Lauck S; Lee M; Gao M; Humphries K; Chan A; Cheung A; Cook R; Della Siega A; Leipsic J; Charania J; Dvir D; Latham T; Polderman J; Robinson S; Wong D; Thompson CR; Wood D; Ye J; Webb J
JACC Cardiovasc Interv; 2015 Dec; 8(15):1944-1951. PubMed ID: 26738663
[TBL] [Abstract][Full Text] [Related]
63. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve.
Webb J; Gerosa G; Lefèvre T; Leipsic J; Spence M; Thomas M; Thielmann M; Treede H; Wendler O; Walther T
J Am Coll Cardiol; 2014 Dec; 64(21):2235-43. PubMed ID: 25456759
[TBL] [Abstract][Full Text] [Related]
64. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
[TBL] [Abstract][Full Text] [Related]
65. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.
Conradi L; Schaefer A; Seiffert M; Schirmer J; Schaefer U; Schön G; Blankenberg S; Reichenspurner H; Treede H; Diemert P
Clin Res Cardiol; 2015 Sep; 104(9):735-42. PubMed ID: 25725778
[TBL] [Abstract][Full Text] [Related]
66. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
67. Radiation dose of patients undergoing transcatheter aortic valve implantation: a comparison between Edwards SAPIEN XT and Medtronic CoreValve aortic valve prostheses.
Steinvil A; Aviram G; Konigstein M; Abramowitz Y; Halkin A; Arbel Y; Ben-Gal Y; Keren G; Banai S; Finkelstein A
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E578-82. PubMed ID: 23592438
[TBL] [Abstract][Full Text] [Related]
68. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
[TBL] [Abstract][Full Text] [Related]
69. Suprasternal Transcatheter Aortic Valve Replacement in Patients With Marginal Femoral Access.
Kiser AC; Caranasos TG; Peterson MD; Holzhey DM; Kiefer P; Nifong LW; Borger MA
Innovations (Phila); 2018; 13(1):1-4. PubMed ID: 29462049
[TBL] [Abstract][Full Text] [Related]
70. The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation?
Beller CJ; Schmack B; Seppelt P; Arif R; Bekeredjian R; Krumsdorf U; Katus HA; Karck M; Kallenbach K
Clin Res Cardiol; 2013 Feb; 102(2):111-7. PubMed ID: 22864650
[TBL] [Abstract][Full Text] [Related]
71. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
[TBL] [Abstract][Full Text] [Related]
72. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
[TBL] [Abstract][Full Text] [Related]
73. Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: a PARTNER trial substudy.
Shreenivas SS; Lilly SM; Szeto WY; Desai N; Anwaruddin S; Bavaria JE; Hudock KM; Thourani VH; Makkar R; Pichard A; Webb J; Dewey T; Kapadia S; Suri RM; Xu K; Leon MB; Herrmann HC
Catheter Cardiovasc Interv; 2015 Aug; 86(2):316-22. PubMed ID: 25546704
[TBL] [Abstract][Full Text] [Related]
74. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
75. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
[TBL] [Abstract][Full Text] [Related]
76. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
77. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients.
Jilaihawi H; Chakravarty T; Weiss RE; Fontana GP; Forrester J; Makkar RR
Catheter Cardiovasc Interv; 2012 Jul; 80(1):128-38. PubMed ID: 22415849
[TBL] [Abstract][Full Text] [Related]
78. Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien(©) valves: a single center experience.
McCabe JM; Huang PH; Riedl LA; Devireddy SR; Grondell J; Connors AC; Davidson MJ; Eisenhauer AC; Welt FG
Catheter Cardiovasc Interv; 2014 Mar; 83(4):633-41. PubMed ID: 24123706
[TBL] [Abstract][Full Text] [Related]
79. Valve-in-Valve Procedures in Failing Biological Xenografts Using a Novel Balloon-Expandable Device: Experience in Aortic, Mitral, and Tricuspid Positions.
Schaefer A; Conradi L; Seiffert M; Lubos E; Blankenberg S; Reichenspurner H; Schaefer U; Treede H
Thorac Cardiovasc Surg; 2016 Aug; 64(5):366-73. PubMed ID: 26277078
[TBL] [Abstract][Full Text] [Related]
80. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
Martinez CA; O'Neill B; Singh V; O'Neill WW
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
